Article Sidebar
Published:
Apr 8, 2016Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Anti-neuroinflammatory Effects of Ethanol Extract of <i>Inula helenium</i> L (Compositae)
Abstract
Purpose: To evaluate the in vitro antioxidant and anti- neuroinflammatory activities of Inula helenium extract (IHE) against lipopolysaccharide (LPS)-induced production of nitric oxide (NO) by primary microglial cells.
Methods: Cell viability was estimated by 3-(4, 5-dimethylthiazol-2- yl)-2, 5- diphenyl-tetrazolium bromide (MTT) assay. Antioxidant activity was evaluated using 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging assay. LPS-stimulated BV-2 microglia were used to study the expression and production of inflammatory mediators, including NO, inducible NO synthase (iNOS)and Interukin-6 (IL-6).
Results: Pretreatment with IHE prior to LPS treatment significantly inhibited excessive production of NO (p < 0.001 at 20, 40, 80 and 100 μg/mL) in a dose-dependent manner, and was associated with downregulation of expression of inducible nitric oxide synthase (iNOS). IHE also suppressed the LPSinduced increase in IL-6 level (p < 0.01 at 40 and 80 μg/mL) in BV-2 cells. The antioxidant activity exhibited by IHE might play a critical role in ameliorating neuroinflammatory processes in LPSstimulated BV-2 microglial cells.
Conclusion: IHE may be beneficial in preventing and treating neurodegenerative and oxidative stressrelated diseases.
Keywords: Inula helenium, DPPH, Neurodegenerative diseases, Anti inflammatory, Anti-oxidant, Microglial cell
